Venous access in haemophilic children: Choice and management

Haemophilia

Volumn 16, Issue SUPPL. 1, 2010, Pages 20-24

  Santagostino, E ^a   Mancuso, M E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Children; Haemophilia; Venous access

Indexed keywords

ARTERIOVENOUS FISTULA; ARTERIOVENOUS SHUNT; ARTICLE; CATHETER INFECTION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETERIZATION; CHILD; CHILD CARE; HEMOPHILIA; HUMAN; PERIPHERAL VEIN; PRIORITY JOURNAL; RISK FACTOR; VASCULAR ACCESS; VASCULAR ACCESS DEVICE;

ARTERIOVENOUS SHUNT, SURGICAL; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; EQUIPMENT CONTAMINATION; FACTOR VIII; HEMOPHILIA A; HUMANS; INFECTION CONTROL;

EID: 73949125216     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02156.x     Document Type: Article

References (25)

1. Manco-Johnson MJ, Abshire TC, Shapiro AD. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007, 357:535-44.
2. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003, 9:418-35.
3. DiMichele DM, Hoots K, Pipe SW, Rivard GE, Santagostino E. International workshop on immune tolerance induction: consensus recommendations. Haemophilia 2007, 13(Suppl. 1):1-22.
4. Valentino LA, Ewenstein B, Navickis RJ, Wilkes MM. Central venous access devices in haemophilia. Hemophilia 2004, 10:134-46.
5. Santagostino E, Gringeri A, Berardinelli L, Beretta C, Muça-Perja M, Mannucci PM. Long-term safety and feasibility of artriovenous fistulae as vascular accesses in children with haemophilia: a prospective study. Br J Haematol 2003, 123:502-6.
6. McCarthy WJ, Valentino LA, Bonilla AS. Arteriovenous fistula for long-term venous access for boys with hemophilia. J Vasc Surg 2007, 45:986-91.
7. Mancuso ME, Berardinelli L, Beretta C, Raiteri M, Pozzoli E, Santagostino E. Improved treatment feasibility in children with hemophilia using arteriovenous fistula: the results after seven years of follow-up. Haematologica 2009, 94:687-92.
8. Petrini P. How to start prophylaxis. Haemophilia 2003, 9(Suppl. 1):83-7.
9. Feldman BM, Pai M, Rivard GE. Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study. J Thromb Haemost 2006, 4:1228-36.
10. Perkins JL, Johnson VA, Osip JM. The use of implantable venous access devices (IVADs) in children with hemophilia. J Pediatr Hematol Oncol 1997, 19:339-44.
11. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991, 338:339-43.
12. Bollard CM, Teague LR, Berry EW, Ockelford PA. The use of central venous catheters (portacaths) in children with haemophilia. Hemophilia 2000, 6:66-70.
13. Fontes B, Ferreira Filho AA, Carelli CR, Fontes W, Birolini D, Bevilacqua RJ. Percutaneous catheterization of the subclavian vein in hemophiliac patients: report of 47 cases. Int Surg 1992, 77:118-21.
14. Liesner RJ, Vora AJ, Hann IM, Lilleyman JS. Use of central venous catheters in children with severe congenital coagulopathy. Br J Haematol 1995, 91:203-7.
15. Ljung R, van den Berg M, Petrini P. Port-A-Cath usage in children with haemophilia: experience of 53 cases. Acta Paediatr 1998, 87:1051-4.
16. Santagostino E, Gringeri A, Muça-Perja M, Mannucci PM. A prospective clinical trial of implantable central venous access in children with haemophilia. Br J Haematol 1998, 102:1224-8.
17. Collins PW, Khair KS, Liesner R, Hann IM. Complications experienced with central venous catheters in children with congenital bleeding disorders. Br J Haematol 1997, 99:206-8.
18. DiMichele DM, Hay CR. The international immune tolerance study: a multicenter prospective randomized trial in progress. J Thromb Haemost 2006, 4:2271-3.
19. Tarantino MD, Lail A, Donfield SM. Surveillance of infectious complications associated with central venous access devices in children with haemophilia. Haemophilia 2003, 9:588-92.
20. McMahon C, Smith J, Khair K, Liesner J, Hann IM, Smith OP. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome. Br J Haematol 2000, 110:461-8.
21. Mancuso ME, Mannucci PM, Sartori A, Agliardi A, Santagostino E. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters. Br J Haematol 2008, 141:689-95.
22. Vidler V, Richards M, Vora A. Central venous catheter-associated thrombosis in severe haemophilia. Br J Haematol 1999, 104:461-4.
23. Journeycake JM, Quinn CT, Miller KL, Zajac JL, Buchanan GR. Catheter-related deep vein thrombosis in children with hemophilia. Blood 2001, 98:1727-31.
24. Price V, Carcao MD, Connolly BL. A prospective, longitudinal study of central venous catheter-related deep vein thrombosis in boys with hemophilia. J Thromb Haemost 2004, 2:737-42.
25. Male C, Chait P, Andrew M. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood 2003, 101:4273-8.